GlobeNewsWire
25 Sept 2026, 11:45 UTC · 1h ago
Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD
Verdict
Headline leans bullish. We score AIFF +0.80 across three claims.
Score confirms the headline.
- Headline says
Leans bullish
From its wording — no explicit rating
- Expected · AIFF
+0.80strongly bullish





